The relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis

Respiratory Investigation

Volumn 50, Issue 2, 2012, Pages 40-45

  Sato, Suguru ^a   Tanino, Yoshinori ^a   Saito, Junpei ^a   Nikaido, Takefumi ^a   Inokoshi, Yayoi ^a   Fukuhara, Atsuro ^a   Fukuhara, Naoko ^a   Wang, Xintao ^a   Ishida, Takashi ^a   Munakata, Mitsuru ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

25 hydroxyvitamin D; Pulmonary tuberculosis; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; TUBERCULOSTATIC AGENT; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MALE; PREDICTION; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK; SPUTUM; TUBERCULOSIS, PULMONARY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84868295210     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.05.002     Document Type: Article

References (24)

1. World Health Organization Global tuberculosis control: WHO report 2010. WHO/HTM/TB/2010.7 2010, World Health Organization, Geneva, Switzerland.
2. 3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 1987, 55:2945-2950.
3. 3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
4. Compston JE Vitamin D deficiency: time for action. BMJ 1998, 317:1466-1467.
5. Holick MF Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
6. Nnoaham KE, Clarke A Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37:113-119.
7. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176:208-213.
8. Nursyam EW, Amin Z, Rumende CM The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38:3-5.
9. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
11. 3. Blood 2005, 106:3490-3497.
12. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
13. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of Mycobacteria: the role of cathelicidin LL-37. J Immunol 2007, 178:7190-7198.
14. 3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 2009, 29:470-478.
15. Ellman P, Anderson K Calciferol in tuberculosis peritonitis with disseminated tuberculosis. BMJ 1948, 1:394.
16. Grad R Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm Hist 2004, 46:106-120.
17. Sita-Lumsden A, Lapthorn G, Swaminathan R, et al. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007, 62:1003-1007.
18. Nakamura K, Nashimoto M, Matsuyama S, et al. Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition 2001, 17:921-925.
19. Nanri A, Foo LH, Nakamura K, et al. Serum 25-hydroxyvitamin D concentrations and season-specific correlates in Japanese adults. J Epidemiol 2011, 21:346-353.
20. Gordon CM, DePeter KC, Feldman HA, et al. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004, 158:531-537.
21. Sullivan SS, Rosen CJ, Halteman WA, et al. Adolescent girls in Maine at risk for vitamin D insufficiency. J Am Diet Assoc 2005, 105:971-974.
22. Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012, 188:2127-2135.
23. Gao L, Tao Y, Zhang L, et al. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010, 14:15-23.
24. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250.